Cargando…
New players in the treatment of hypercholesterolaemia: focus on bempedoic acid and inclisiran
Dyslipidaemias and in particular elevated plasma low-density lipoprotein cholesterol (LDL-C) levels are major risk factors for atherosclerotic cardiovascular disease (ASCVD). Indeed, the more LDL-C is reduced the larger will be the ASCVD risk reduction. Although statins represent the first-line inte...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503511/ https://www.ncbi.nlm.nih.gov/pubmed/34650356 http://dx.doi.org/10.1093/eurheartj/suab090 |